Form 8-K - Current report:
SEC Accession No. 0001640334-22-001683
Filing Date
2022-08-09
Accepted
2022-08-09 08:05:56
Documents
18
Period of Report
2022-08-08
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 30819
2 CERTIFICATE OF CHANGE artl_ex31.htm EX-3.1 1107
3 PRESS RELEASE artl_ex991.htm EX-99.1 17485
9 artl_ex31img1.jpg GRAPHIC 219988
10 artl_ex991img1.jpg GRAPHIC 5012
  Complete submission text file 0001640334-22-001683.txt   497979

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20220808.xsd EX-101.SCH 5735
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20220808_lab.xml EX-101.LAB 15735
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20220808_cal.xml EX-101.CAL 908
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20220808_pre.xml EX-101.PRE 10003
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20220808_def.xml EX-101.DEF 2109
12 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 3822
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 221146495
SIC: 2834 Pharmaceutical Preparations